Table 4

Associations of clinical variables with psoriasis flares

Patients with psoriasis flaresPatients without psoriasis flaresP value
Immunotherapy class0.27
 Anti-PD-1/PD-L132 (42%)19 (25%)
 Anti-CTLA-43 (4%)5 (7%)
 Combination PD-1/CTLA-4 blockade8 (11%)9 (12%)
Psoriasis therapy0.077
 Prior psoriasis therapy27 (63%)14 (42%)
 No prior psoriasis therapy16 (37%)19 (58%)
Time on therapy168 days63 days0.019